Respiratory Infection and Otitis Media Visits in Relation to Pneumococcal Conjugate Vaccine Use in Saskatchewan
BACKGROUND: In Saskatchewan, pneumococcal conjugate vaccination (PCV) was offered to high-risk children in 2002 and to all infants in 2005.
Saved in:
Main Authors: | Ngoc-Hang Khuc, Ben Tan, Rosalie Tuchscherer, Nigel SB Rawson, Philippe De Wals |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2013/385652 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
by: Susanna Esposito, et al.
Published: (2015-01-01) -
Respiratory Medicine in Saskatchewan: An Historical Perspective
by: Donald W Cockcroft
Published: (2015-01-01) -
Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia
by: Karyn L. Sutton, et al.
Published: (2007-12-01) -
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
by: Tao Chen, et al.
Published: (2022-07-01) -
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
by: Ting-An Yen, et al.
Published: (2025-02-01)